M
Marcin Włodarczyk
Researcher at Medical University of Łódź
Publications - 90
Citations - 893
Marcin Włodarczyk is an academic researcher from Medical University of Łódź. The author has contributed to research in topics: Inflammatory bowel disease & Crohn's disease. The author has an hindex of 14, co-authored 78 publications receiving 533 citations. Previous affiliations of Marcin Włodarczyk include University of Łódź.
Papers
More filters
Journal ArticleDOI
The role of microbiota-gut-brain axis in neuropsychiatric and neurological disorders.
Katarzyna Socała,Urszula Doboszewska,Aleksandra Szopa,Anna Serefko,Marcin Włodarczyk,Anna Zielińska,Ewa Poleszak,Jakub Fichna,Piotr Wlaź +8 more
TL;DR: This review summarizes recent data on the role of microbiota-gut-brain axis in the pathophysiology of neuropsychiatric and neurological disorders including depression, anxiety, schizophrenia, autism spectrum disorders, Parkinson's disease, migraine, and epilepsy.
Journal ArticleDOI
Latent M. tuberculosis infection--pathogenesis, diagnosis, treatment and prevention strategies
Magdalena Druszczyńska,Magdalena Kowalewicz-Kulbat,Marek Fol,Marcin Włodarczyk,Wiesława Rudnicka +4 more
TL;DR: From the clinical point of view detection of latent TB infections (LTBI) in individuals with the highest active TB risk including cases of HIV infection, autoimmune inflammatory diseases or cancer, is a priority.
Journal ArticleDOI
Treatment of the Fluoroquinolone-Associated Disability: The Pathobiochemical Implications
Krzysztof Piotr Michalak,Aleksandra Sobolewska-Włodarczyk,Marcin Włodarczyk,Justyna Sobolewska,Piotr Woźniak,Bogusław Sobolewski +5 more
TL;DR: The main directions of possible effective treatment of FQAD are proposed: reduction of the oxidative stress, restoring reduced mitochondrion potential ΔΨm, and supplementation of uni- and bivalent cations that are chelated by FQs and probably ineffectively transported to the cell.
Journal ArticleDOI
Focus on current and future management possibilities in inflammatory bowel disease-related chronic pain.
TL;DR: There is no one standardized method of managing chronic visceral pain in IBD, so future development, focusing primarily on alleviating the pain, but also on reducing inflammation, is essential.
Journal ArticleDOI
Correlations between skin lesions induced by anti-tumor necrosis factor-α and selected cytokines in Crohn's disease patients.
Marcin Włodarczyk,Aleksandra Sobolewska,Bartosz Wójcik,Karolina Loga,Jakub Fichna,Maria Wiśniewska-Jarosińska +5 more
TL;DR: Skin lesions in Crohn's disease patients during biological therapy may result from significantly increased concentrations of IL-17A and IL-23, which are strongly associated with TNF-α/Th1 immune pathways.